Certain Stock Option of Deciphera Pharmaceuticals, Inc. are subject to a Lock-Up Agreement Ending on 26-JUL-2022. These Stock Option will be under lockup for 91 days starting from 26-APR-2022 to 26-JUL-2022.

Details:
The directors, executive officers, and certain of stockholders holding an aggregate of 48,399,000 shares of common stock as of December 31, 2021 have entered into lock-up agreements with the underwriters prior to the commencement of this offering pursuant to which each of these persons or entities, with limited exceptions, for a period of 90 days after the date of this prospectus supplement, may not, without the prior written consent of the representatives, (1) offer, pledge, sell, contract to sell, sell any option or contract to purchase, purchase any option or contract to sell, grant any option, right or warrant to purchase, or otherwise transfer or dispose of, directly or indirectly, any shares of common stock or any securities convertible into or exercisable or exchangeable for common stock (including without limitation, common stock or such other securities.